Search

Lynne E Maquat

from Rochester, NY
Age ~72
Get Report
Also known as:
Lynne Dr Maquat, Lynne E Macquat, Lynne Rochester, Aquatt M Lynne
Phone and address:
1484 East Ave, Rochester, NY 14610
(585) 442-4334
Connected to:
Darla Maqueda, 55Joaquin E Maqueda, 42Pablo Maqueda, 61Carmen H Maqueira, 69Christine M Maqueira, 79Julia Maqueira, 63Maribel Maqueira, 63Yvonne M Maquera, 85Aaron J Maquet, 52Corine Maquet, 49

Lynne Maquat Phones & Addresses

  • 1484 East Ave, Rochester, NY 14610 (585) 442-4334
  • 1100 East Ave, Rochester, NY 14607
  • 237 Lakefront Blvd, Buffalo, NY 14202
  • 125 Windsor Ave, Buffalo, NY 14209
  • 1484 East Ave, Rochester, NY 14610

Public records

Vehicle Records

Lynne Maquat

View page
Address:
1484 East Ave, Rochester, NY 14610
Phone:
(585) 442-4334
VIN:
WBAVB73567VF50607
Make:
BMW
Model:
3 SERIES
Year:
2007

Publications

Us Patents

Methods And Compositions Related To Staufen 1 Binding Sites Formed By Duplexing Alu Elements

View page
US Patent:
20130317087, Nov 28, 2013
Filed:
Feb 9, 2012
Appl. No.:
13/984709
Inventors:
Lynne E. Maquat - Rochester NY, US
Chenguang Gong - Rochester NY, US
Assignee:
UNIVERSITY OF ROCHESTER - Rochester NY
International Classification:
C12Q 1/68
US Classification:
514 44 A, 436501, 506 9, 435 612, 536 245
Abstract:
Disclosed are compositions and methods for identifying binding sites of targets of Staul-mediated mRNA decay; methods and compositions for treating subjects with conditions resulting from Staul-mediated mRNA decay, and method of screening for therapeutic agents. Also disclosed is the new pathway as a means for cells to down-regulate the expression of Staul-binding mRNAs.

Nonsense-Mediated Mrna Decay

View page
US Patent:
20060154883, Jul 13, 2006
Filed:
Aug 21, 2003
Appl. No.:
10/525273
Inventors:
Lynne Maquat - Rochester NY, US
International Classification:
A61K 48/00
US Classification:
514044000
Abstract:
Disclosed are compositions and methods relating to nonsense mediated decay (NMD) particularly in the “pioneer” round of translation. The present invention provides methods of treating disorders relating to NMD and methods of screening substances for use in the study of or treatment of conditions relating to NMD.

Compositions And Methods For Inhibiting Cbp80 Binding To Pgc1 Family Of Co-Activators

View page
US Patent:
20180362587, Dec 20, 2018
Filed:
Dec 8, 2016
Appl. No.:
16/060109
Inventors:
- Rochester NY, US
Lynne Maquat - Rochester NY, US
Rudi Fasan - Rochester NY, US
International Classification:
C07K 7/08
A61K 38/10
A61K 45/06
A61P 35/00
Abstract:
The invention provides compositions and methods for inhibiting protein-protein interactions with cap-binding protein 80 (CBP80). In one embodiment, the invention provides compositions comprising linear and macrocylic peptides. In one embodiment, the invention provides methods for treating cancer, heart disease, autoimmune disorders, obesity, diabetes, or chronic inflammation disorders associated with the PGC1 family of co-activators.

Compositions And Methods For Treating Cancer

View page
US Patent:
20160279110, Sep 29, 2016
Filed:
Mar 28, 2016
Appl. No.:
15/082750
Inventors:
Lynne E. Maquat - Rochester NY, US
Maximilian W. Popp - Rochester NY, US
Assignee:
UNIVERSITY OF ROCHESTER - Rochester NY
International Classification:
A61K 31/4375
A61K 31/704
Abstract:
Provided herein are compositions and methods for treating cancer.
Control profile
Lynne E Maquat from Rochester, NY, age ~72 Get Report